A major healthcare technology acquisition appears to be moving forward, with life sciences corporation Danaher reportedly nearing completion of a massive deal to purchase medical monitoring company Masimo for approximately $10 billion, according to a Financial Times report published Monday.
Sources with knowledge of the negotiations told the Financial Times that the substantial transaction could be announced as early as Tuesday, assuming no final obstacles emerge.
Neither Danaher nor Masimo provided immediate responses when contacted for comment about the reported acquisition. Reuters was unable to independently confirm the Financial Times reporting.
The medical monitoring technology company Masimo currently carries a market value of roughly $7 billion based on current stock calculations.
